Global Budesonide Capsules Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Budesonide Capsules Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
Budesonide Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Budesonide Capsules market is projected to reach US$ 1646.3 million in 2029, increasing from US$ 902.3 million in 2022, with the CAGR of 9.1% during the period of 2024 to 2029. Demand from Crohn's Disease and Collagenous Colitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Budesonide Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Budesonide Capsules key manufacturers include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc. Perrigo, Mylan, Tillotts Pharma are top 3 players and held % sales share in total in 2022.
Budesonide Capsules can be divided into 1mg, 2mg and 3mg,, etc. 1mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Budesonide Capsules is widely used in various fields, such as Crohn's Disease, Collagenous Colitis and Autoimmune Hepatitis,, etc. Crohn's Disease provides greatest supports to the Budesonide Capsules industry development. In 2022, global % sales of Budesonide Capsules went into Crohn's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Budesonide Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Segment by Type
1mg
2mg
3mg
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Budesonide Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Budesonide Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Budesonide Capsules industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Budesonide Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Budesonide Capsules introduction, etc. Budesonide Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Budesonide Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Budesonide Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Budesonide Capsules market is projected to reach US$ 1646.3 million in 2029, increasing from US$ 902.3 million in 2022, with the CAGR of 9.1% during the period of 2024 to 2029. Demand from Crohn's Disease and Collagenous Colitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Budesonide Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Budesonide Capsules key manufacturers include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc. Perrigo, Mylan, Tillotts Pharma are top 3 players and held % sales share in total in 2022.
Budesonide Capsules can be divided into 1mg, 2mg and 3mg,, etc. 1mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Budesonide Capsules is widely used in various fields, such as Crohn's Disease, Collagenous Colitis and Autoimmune Hepatitis,, etc. Crohn's Disease provides greatest supports to the Budesonide Capsules industry development. In 2022, global % sales of Budesonide Capsules went into Crohn's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Budesonide Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Segment by Type
1mg
2mg
3mg
Segment by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Budesonide Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Budesonide Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Budesonide Capsules industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Budesonide Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Budesonide Capsules introduction, etc. Budesonide Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Budesonide Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices